An official website of the United States government.

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Structural Basis of Erm-mediated Macrolide Resistance

Investigators
Polikanov, Yury; Mankin, Alexander S
Institutions
University of Illinois - Chicago
Start date
2018
End date
2019
Objective
SUMMARYMacrolide antibiotics are among the most clinically important antibacterial agents. They inhibit cell growth bybinding to the ribosome in the nascent peptide exit tunnel and interfering with protein synthesis.Crystallographic structures of the ribosome complexed to macrolide antibiotics revealed the main sites ofcontact, including the key interaction with adenine residue A2058 (using Escherichia coli numbering), which isuniversally conserved in bacteria. One of the main mechanisms of resistance to macrolides is dimethylation ofA2058 by the Erm-type rRNA methyltransferases. This modification also confers resistance to other classes ofribosome targeting antibiotics, including lincosamides and streptogramins B. The structure of the macrolide-binding site in the Erm-modified ribosome is unknown. Although possible explanations for the effect of A2058dimethylation on drug binding have been proposed, they cannot account for the available experimental data.Therefore, at the moment, there is no satisfactory explanation of why dimethylation of A2058 by Ermmethyltransferase prevents antibiotic binding. The lack of this knowledge precludes rational development ofnewer macrolides and other antibiotics that would maintain clinically relevant activities against the Erm-modified ribosome.In the proposed project, we will solve this long-standing problem by obtaining the crystallographic structure ofthe Erm-modified bacterial ribosome in isolation or in complex with antibiotics exhibiting residual activityagainst the A2058 dimethylated ribosome. To achieve this goal, we will optimize the expression of functionally-active Erm methyltransferases in the cells of thermophilic bacterium Thermus thermophilus, which has beenused as the source of ribosomes suitable for crystallographic studies. We have found that in spite of growingoptimally at 72-75°C, T. thermophilus can grow at notably lower temperatures. By cloning and expressing Erm-methyltransferase genes from moderately thermophilic bacteria in T. thermophilus grown at high temperaturesor by expressing the erm genes from the mesophilic bacteria in the T. thermophilus host grown at reducedtemperatures, we will obtain the crystallizable ribosome dimethylated at A2058. Once the atomic structure ofthe vacant Erm-modified ribosome is obtained, we will solve the structures of the Erm-modified ribosomescomplexed with several macrolides which retain residual activity against the Erm-modified ribosome. Theresulting information will be instrumental for understanding the molecular principles of Erm-mediatedresistance and will inform the subsequent rational design of new antibacterials active against Erm-positivepathogens.
Funding Source
Nat'l. Inst. of Allergy and Infectious Diseases
Project source
View this project
Project number
1R21AI137584-01
Categories
Viruses and Prions
Antimicrobial Resistance
Bacterial Pathogens